(Q37811625)

23 August 2017

title

Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders (English)

1 reference

23 August 2017

0 references

0 references

0 references

2

0 references

author name string

Bart M Vanaudenaerde

1

1 reference

23 August 2017

Robin Vos

3

1 reference

23 August 2017

Stéphanie I De Vleeschauwer

4

1 reference

23 August 2017

Anna Willems-Widyastuti

5

1 reference

23 August 2017

Rachel Geenens

6

1 reference

23 August 2017

Dirk E Van Raemdonck

7

1 reference

23 August 2017

Lieven J Dupont

8

1 reference

23 August 2017

Erik K Verbeken

9

1 reference

23 August 2017

Isabelle Meyts

10

1 reference

23 August 2017

language of work or name

English

0 references

publication date

19 November 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

23 August 2017

published in

1 reference

23 August 2017

volume

183

1 reference

23 August 2017

issue

8

1 reference

23 August 2017

page(s)

977-986

1 reference

Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Regulation of IL-17 production in human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Regulation of human Th9 differentiation by type I interferons and IL-21

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Follicular helper T cells: lineage and location

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

T follicular helper (TFH) cells in normal and dysregulated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Development, cytokine profile and function of human interleukin 17-producing helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

The functional plasticity of T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

NKT cells: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Lymphoid tissue inducer cells: architects of CD4 immune responses in mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Innate IL-17-producing cells: the sentinels of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Recent patents and new strategies in the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Obliterative bronchiolitis following lung transplantation: from old to new concepts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Antielastin autoimmunity in tobacco smoking-induced emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

TH17 cells in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Interleukin-17 and lung host defense against Klebsiella pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Induction, function and regulation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Is cystic fibrosis a TH17 disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Immunology of asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

The development of immunotherapies for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

The safety and side effects of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Manipulation of T(H)17 responses in pulmonary immunity and disease through vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Anti-inflammatory effects of macrolides in lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Vitamin effects on the immune system: vitamins A and D take centre stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Protein geranylgeranylation regulates the balance between Th17 cells and Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201007-1196PP

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

21 January 2018

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI40202

Identifiers

DOI

10.1164/RCCM.201007-1196PP

1 reference

23 August 2017

1 reference